COMMENTARY

• Interim Report of Diovan Committee Raises Further Questions
  October 15, 2013

• Remicade Biosimilar Debut Awaited in FY2014; Good Opportunity to Revisit Healthcare Finance?
  October 4, 2013

• Comprehensive Review of Package Inserts to Begin with Effort to Identify Inconsistencies Between Inserts for Similar Drugs
  August 27, 2013

• Transparency Guidelines Go Live, Will It Help Pharmas Win Public Trust?
  August 2, 2013

• Overseas Outlook Will Be Essential to Survival and Progress of Domestic CROs
  June 24, 2013

• PMDA’s Seriousness About Becoming a Leading Global Regulatory Authority to Be Tested
  May 30, 2013

• Beyond Risk Management: RMPs Provide Opportunity for Post-Marketing Drug Development and Product Differentiation
  May 8, 2013

• Iressa Cases Signal Risks Hiding in Daily Clinical Practices
  April 22, 2013

• Will Drugs that Fight Cancer Stem Cells Succeed? Domestic Clinical Trial by DSP on the Horizon
  March 15, 2013

• Gov’t, Industry to Support Developing Countries through Development of Drugs for Infectious Diseases; Hoping to Secure Future Business Opportunities as Well
  February 27, 2013

• What Next for a “Mature” ICH? What More Can Be Done Beyond Regulatory Harmonization?
  January 22, 2013

• Hot Products in 2013: New Drugs Likely to Jolt RA Treatment, Anticoagulant Markets
  January 8, 2013

• Counterfeit Drugs: Risks Lurking in Globalization
  December 28, 2012

• Can Japan Craft Its Own “Compassionate Use” System without Spoiling Drug Makers’ Development Drives?
  December 7, 2012

• Recent Announcements of Suspended Product Supplies Highlight Supply Risks Faced by Generic Drug Industry
  November 27, 2012

• Will Integration of Domestic Makers Be Enough for Sustainable Plasma Fractionation Operations?
  November 16, 2012

• Approval of Switch-OTC Epadel Puts Spotlight on Quality, Track Record of Pharmacists
  November 9, 2012

• Final Preparations Underway for Trial Run of Medical Database
  September 25, 2012

• Competition Getting Fiercer in COPD Drug Market
  September 13, 2012

• FY2013 Budget Expected to Have Positive Impact on Pharmaceutical and Medical Device Industries
  August 30, 2012

ページ